Professor Seymour is the director of Cancer Medicineat Peter Mac anda member of many scientific committees including the Victorian Government Consultative Council on Human Research Ethics, Scientific Advisory Committees for the International Workshop on NHL, International Conference on Malignant Lymphoma, and Board of Directors of the International Extranodal Lymphoma Study Group. He is a past Chairman of the Australasian Leukaemia and Lymphoma Group and is a frequently invited speaker nationally and internationally. He is the Editor-in-Chief of Leukemia and Lymphoma and on the editorial boards of the Journal of Clinical Oncology, British Journal of Haematology, and Leukemia Research. He has also authored 13 book chapters, more than 300 peer-reviewed publications (which have been cited more than 8,000 times), and 500 conference abstracts. Heavily committed to clinical and translational research, Professor Seymour is national study chairman for 12 ongoing national or international clinical trials.

LYMPHOPROLIFERATIVE DISORDERS (CLL, NHL, HL)